Cargando…
Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556166/ https://www.ncbi.nlm.nih.gov/pubmed/33110621 http://dx.doi.org/10.1177/2055217320966346 |
| _version_ | 1783594167764516864 |
|---|---|
| author | Margoni, Monica Gallo, Paolo |
| author_facet | Margoni, Monica Gallo, Paolo |
| author_sort | Margoni, Monica |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7556166 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75561662020-10-26 Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic Margoni, Monica Gallo, Paolo Mult Scler J Exp Transl Clin Letter SAGE Publications 2020-10-12 /pmc/articles/PMC7556166/ /pubmed/33110621 http://dx.doi.org/10.1177/2055217320966346 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter Margoni, Monica Gallo, Paolo Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic |
| title | Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic |
| title_full | Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic |
| title_fullStr | Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic |
| title_full_unstemmed | Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic |
| title_short | Natalizumab safety in paediatric-onset multiple sclerosis at the time of SARS-Cov-2 pandemic |
| title_sort | natalizumab safety in paediatric-onset multiple sclerosis at the time of sars-cov-2 pandemic |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556166/ https://www.ncbi.nlm.nih.gov/pubmed/33110621 http://dx.doi.org/10.1177/2055217320966346 |
| work_keys_str_mv | AT margonimonica natalizumabsafetyinpaediatriconsetmultiplesclerosisatthetimeofsarscov2pandemic AT gallopaolo natalizumabsafetyinpaediatriconsetmultiplesclerosisatthetimeofsarscov2pandemic |